BrainCells
BrainCells is a biotechnology startup focused on drugs intended to stimulate the growth of new neurons.
Business Model:
Revenue: $16.6M
Employees: 51-200
Rankings
Industries / Tags:
Detailed BrainCells Information
Geographic Data
Address: 3636 Nobel Dr
City: San Diego
State: CA
Zip: 92122
Country: US
Financial Info
Stage:
debt financing
Raised Last:
$2M
Raised Total:$74M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
BrainCells develops and provides biopharmaceutical products for the treatment of central nervous system (CNS) diseases. It develops compounds that promote the growth of new neurons for the treatment of major depressive disorder (MDD), treatment resistant depression (TRD), and potentially Alzheimer’s disease (AD). The company&s;s products include BCI-838 and BCI-632 which increase synaptic glutamate by inhibiting the mGlu2/3 auto-receptor. The company also builds a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes, and other CNS disorders. The company was founded in 2003 and is based in San Diego, California.
Contact Phone:
+18588127700
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2012 | Debt Financing | $2M | 4/2008 | Series B | 2 | $20M |
Alexandria Real Estate Equities New Enterprise Associates Alexandria Real Estate Equities New Enterprise Associates |
3/2008 | Series B | 6 | $30M |
Bay City Capital MedImmune Ventures NeuroVentures Oxford Bioscience Partners Pappas Ventures Technology Partners Bay City Capital MedImmune Ventures NeuroVentures Oxford Bioscience Partners Pappas Ventures Technology Partners |
8/2011 | Debt Financing | $4M | 7/2005 | Series A | $0 |
Oxford Bioscience Partners Bay City Capital Bay City Capital Oxford Bioscience Partners NeuroVentures A. M. Pappas &a; Associates Oxford Bioscience Partners Bay City Capital Bay City Capital Oxford Bioscience Partners NeuroVentures A. M. Pappas &a; Associates |
7/2005 | Series A | 4 | $17.7M |
Oxford Bioscience Partners Bay City Capital Bay City Capital Oxford Bioscience Partners Oxford Bioscience Partners Bay City Capital Bay City Capital Oxford Bioscience Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
